ESTETROL DROSPIRENONE TO REDUCE THE AVERAGE SIZE OF ENDOMETRIOMAS (ERASE)

Registry ID

2024-9147

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

MCGILL UNIVERSITY HEALTH CENTRE RESEARCH INSTITUTE

Start date

2024-10-07

Last update

2024-07-10

Conditions

• ENDOMETRIOMA
• CONTRACEPTION

Related clinical trials

• A PHASE 3, MULTI-CENTER, NON-COMPARATIVE STUDY TO EVALUATE THE CONTRACEPTIVE EFFICACY, SAFETY, AND TOLERABILITY OF LPRI-CF113 ADMINISTERED ORALLY FOR 13 MEDICATION CYCLES

View on source registry